Literature DB >> 10367719

Relationships between muscle mitochondrial DNA content, mitochondrial enzyme activity and oxidative capacity in man: alterations with disease.

H Wang1, W R Hiatt, T J Barstow, E P Brass.   

Abstract

Muscle mitochondrial content is tightly regulated, and requires the expression of both nuclear and mitochondrial genes. In addition, muscle mitochondrial content is a major determinant of aerobic exercise capacity in healthy subjects. The current study was designed to test the hypothesis that in healthy humans, muscle mitochondrial DNA (mtDNA) content is correlated with citrate synthase activity (a representative nuclear-encoded mitochondrial enzyme) and aerobic exercise capacity as defined by whole-body peak oxygen consumption (VO2). Furthermore, it was postulated that these relationships might be altered with disease. Twelve healthy and five paraplegic subjects underwent exercise testing and vastus lateralis muscle biopsy sampling. An additional ten healthy subjects and eight patients with unilateral peripheral arterial disease (PAD) underwent exercise testing and gastrocnemius muscle biopsy sampling. Citrate synthase activity and mtDNA content were positively correlated in the vastus lateralis muscles from the healthy subjects. This relationship was similar in muscle from paraplegic subjects. mtDNA content was positively correlated with peak VO2 in the healthy subjects and in the paraplegic subjects in whom peak VO2 had been elicited by functional electrical stimulation of the muscle. In contrast, the PAD subjects demonstrated higher mtDNA contents than would have been predicted based on their claudication-limited peak VO2. Thus, in healthy humans there are strong relationships between muscle mtDNA content and both muscle citrate synthase activity and peak VO2. These relationships are consistent with coordinant nuclear DNA and mtDNA expression, and with mitochondrial content being a determinant of aerobic exercise capacity. The relationships seen in healthy humans are quantitatively similar in paraplegic patients, but not in patients with PAD, a disease which is associated with a metabolic myopathy. The relationships between mtDNA content, mitochondrial enzyme activities and exercise capacity provide insight into the physiologic and pathophysiologic regulation of muscle mitochondrial expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10367719     DOI: 10.1007/s004210050553

Source DB:  PubMed          Journal:  Eur J Appl Physiol Occup Physiol        ISSN: 0301-5548


  31 in total

1.  Delayed calf muscle phosphocreatine recovery after exercise identifies peripheral arterial disease.

Authors:  David C Isbell; Stuart S Berr; Alicia Y Toledano; Frederick H Epstein; Craig H Meyer; Walter J Rogers; Nancy L Harthun; Klaus D Hagspiel; Arthur Weltman; Christopher M Kramer
Journal:  J Am Coll Cardiol       Date:  2006-05-15       Impact factor: 24.094

2.  Peripheral artery disease, calf skeletal muscle mitochondrial DNA copy number, and functional performance.

Authors:  Mary M McDermott; Charlotte A Peterson; Robert Sufit; Luigi Ferrucci; Jack M Guralnik; Melina R Kibbe; Tamar S Polonsky; Lu Tian; Michael H Criqui; Lihui Zhao; James H Stein; Lingyu Li; Christiaan Leeuwenburgh
Journal:  Vasc Med       Date:  2018-05-08       Impact factor: 3.239

3.  Regional differences in oxidative capacity of rat white adipose tissue are linked to the mitochondrial content of mature adipocytes.

Authors:  Catherine Deveaud; Bertrand Beauvoit; Bénédicte Salin; Jacques Schaeffer; Michel Rigoulet
Journal:  Mol Cell Biochem       Date:  2004-12       Impact factor: 3.396

4.  Role of adiponectin in human skeletal muscle bioenergetics.

Authors:  Anthony E Civitarese; Barbara Ukropcova; Stacy Carling; Matthew Hulver; Ralph A DeFronzo; Lawrence Mandarino; Eric Ravussin; Steve R Smith
Journal:  Cell Metab       Date:  2006-07       Impact factor: 27.287

5.  Regulation of skeletal muscle oxidative capacity and insulin signaling by the mitochondrial rhomboid protease PARL.

Authors:  Anthony E Civitarese; Paul S MacLean; Stacy Carling; Lyndal Kerr-Bayles; Ryan P McMillan; Anson Pierce; Thomas C Becker; Cedric Moro; Jean Finlayson; Natalie Lefort; Christopher B Newgard; Lawrence Mandarino; William Cefalu; Ken Walder; Greg R Collier; Matthew W Hulver; Steven R Smith; Eric Ravussin
Journal:  Cell Metab       Date:  2010-05-05       Impact factor: 27.287

Review 6.  Mitochondrial Dysfunction in Heart Failure With Preserved Ejection Fraction.

Authors:  Anupam A Kumar; Daniel P Kelly; Julio A Chirinos
Journal:  Circulation       Date:  2019-03-12       Impact factor: 29.690

7.  Mice lacking PGC-1β in adipose tissues reveal a dissociation between mitochondrial dysfunction and insulin resistance.

Authors:  Natàlia Enguix; Rosario Pardo; Agustí González; Víctor M López; Rafael Simó; Anastasia Kralli; Josep A Villena
Journal:  Mol Metab       Date:  2013-06-05       Impact factor: 7.422

8.  Mitochondrial DNA content in peripheral blood monocytes: relationship with age of diabetes onsetand diabetic complications.

Authors:  J Wong; S V McLennan; L Molyneaux; D Min; S M Twigg; D K Yue
Journal:  Diabetologia       Date:  2009-07-21       Impact factor: 10.122

9.  p53 improves aerobic exercise capacity and augments skeletal muscle mitochondrial DNA content.

Authors:  Joon-Young Park; Ping-Yuan Wang; Takumi Matsumoto; Ho Joong Sung; Wenzhe Ma; Jeong W Choi; Stasia A Anderson; Scot C Leary; Robert S Balaban; Ju-Gyeong Kang; Paul M Hwang
Journal:  Circ Res       Date:  2009-08-20       Impact factor: 17.367

Review 10.  Intermittent claudication: new targets for drug development.

Authors:  Eric P Brass
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.